Body Vision Medical Raises $20M For Its Lung Cancer Diagnostics And Treatment Tech
Israeli commercial-stage medical device company Body Vision Medical, a firm specializing in lung cancer diagnostics and treatment through real-time software technologies, announced last week that it had completed a $20 million Series C funding round. No details about who led the round were disclosed but its proceeds will be used to streamline commercialization and manufacturing […]
September 29, 2019
Nucleix Announces Positive Results In Study Detecting Lung Cancer
The Israeli Israeli cancer detection company has announced positive results from a clinical study using its Lung EpiCheck blood test identifying early cancer.
September 06, 2018